(Q50926666)

25 March 2018

title

miR-150 promotes the proliferation of lung cancer cells by targeting P53. (English)

1 reference

25 March 2018

1 reference

Ni Zhang

1

1 reference

25 March 2018

Xiang Wei

series ordinal

2

1 reference

25 March 2018

Lijun Xu

series ordinal

3

1 reference

25 March 2018

language of work or name

English

0 references

publication date

6 June 2013

1 reference

25 March 2018

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

FEBS Letters

1 reference

25 March 2018

volume

587

1 reference

25 March 2018

issue

15

1 reference

25 March 2018

page(s)

2346-2351

1 reference

25 March 2018

Genetic influences in common respiratory disorders

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

Environmental factors in causing human cancers: emphasis on tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

Pathogenesis of lung cancer: 100 year report

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

Lung cancer pathogenesis associated with wood smoke exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

Throwing new light on lung cancer pathogenesis: updates on three recent topics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

An overview of lung cancer genomics and proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

Changes in plasma mass-spectral profile in course of treatment of non-small cell lung cancer patients with epidermal growth factor receptor tyrosine kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

Genomic and proteomic profiling of lung cancers: lung cancer classification in the age of targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

miRNAs on the move: miRNA biogenesis and the RNAi machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

miRNAs: whys and wherefores of miRNA-mediated regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

miRNA genetic alterations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

21 January 2018

MicroRNA in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

Causes and consequences of microRNA dysregulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

The role of microRNAs in normal and malignant hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

An in vivo functional screen uncovers miR-150-mediated regulation of hematopoietic injury response

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

Impaired microRNA processing enhances cellular transformation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

The tumor suppressor microRNA let-7 represses the HMGA2 oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

microRNA-34a sensitizes lung cancer cell lines to DDP treatment independent of p53 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

Identification of Differentially Expressed MicroRNAs in Osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

p53-dependent apoptosis pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

DNA-PKcs-mediated stabilization of p53 by JNK2 is involved in arsenite-induced DNA damage and apoptosis in human embryo lung fibroblast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

Regulation of PTEN transcription by p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

p53 has a direct apoptogenic role at the mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.059

10.1016/J.FEBSLET.2013.05.059

21 January 2018

Identifiers

DOI

1 reference

25 March 2018

PubMed ID

23747308

1 reference

25 March 2018